IDH2 and angioimmunoblastic T-cell lymphoma: RHOA mutation (G17V hotspot) was detected in 9 out of 22 cases, DNMT3A in 7 out of 25 cases, and only 3 out of 18 AITL harbored an IDH2 mutation involving the R172 residue.